- Conditions
- Allergic Contact Dermatitis
- Interventions
- EB01 Cream Placebo, EB01 Cream 0.2%, EB01 Cream 1.0%, EB01 Cream 2.0%
- Drug
- Lead sponsor
- Edesa Biotech Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 211 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2023
- U.S. locations
- 14
- States / cities
- Long Beach, California • Washington D.C., District of Columbia • Delray Beach, Florida + 11 more
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 73–96
of 104
matching trials from the live ClinicalTrials.gov search.
- Conditions
- BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and Consistency, Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe, Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe
- Interventions
- clindamycin phosphate vaginal cream 2%, placebo
- Drug · Other
- Lead sponsor
- Actavis Inc.
- Industry
- Eligibility
- 18 Years and older · Female only
- Enrollment
- 604 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2014
- U.S. locations
- 15
- States / cities
- Birmingham, Alabama • La Mesa, California • San Diego, California + 12 more
- Conditions
- Acne Vulgaris
- Interventions
- Visonac PDT, Vehicle cream with PDT
- Drug
- Lead sponsor
- Photocure
- Industry
- Eligibility
- 12 Years to 35 Years
- Enrollment
- 153 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 15
- States / cities
- Oceanside, California • San Diego, California • Jacksonville, Florida + 12 more
- Conditions
- Basal Cell Carcinoma
- Interventions
- 5% Imiquimod cream, Placebo Vehicle Control Cream
- Drug
- Lead sponsor
- VA Office of Research and Development
- Federal
- Eligibility
- 18 Years and older
- Enrollment
- 1,630 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2026 – 2032
- U.S. locations
- 1
- States / cities
- Providence, Rhode Island
- Conditions
- Psoriasis Vulgaris, Topical Administration
- Interventions
- Total coumarin (TC) cream, Vehicle
- Drug
- Lead sponsor
- Psoriasis Research Institute of Guangzhou
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2018
- U.S. locations
- 2
- States / cities
- New York, New York • Seattle, Washington
- Conditions
- Plaque Psoriasis
- Interventions
- Tazarotene Cream 0.05%, TAZORAC® (tazarotene) Cream 0.05%, Placebo
- Drug
- Lead sponsor
- Fougera Pharmaceuticals Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 855 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 30
- States / cities
- Phoenix, Arizona • Hot Springs, Arkansas • Anaheim, California + 25 more
- Conditions
- Acne Vulgaris
- Interventions
- Tazarotene Cream 0.1%, Tazorac®, Placebo
- Drug
- Lead sponsor
- Fougera Pharmaceuticals Inc.
- Industry
- Eligibility
- 12 Years to 40 Years
- Enrollment
- 1,110 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2017
- U.S. locations
- 25
- States / cities
- Tucson, Arizona • Conway, Arkansas • Hot Springs, Arkansas + 20 more
- Conditions
- Actinic Keratosis
- Interventions
- Aldara (imiquimod 5% cream), Vehicle cream
- Drug
- Lead sponsor
- Graceway Pharmaceuticals, LLC
- Industry
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 17 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2003
- U.S. locations
- 1
- States / cities
- Loma Linda, California
- Conditions
- Psoriasis, Plaque Psoriasis
- Interventions
- MK-0873 2% Cream, MK-0873 vehicle (placebo) Cream, Calcitriol Cream
- Drug
- Lead sponsor
- Merck Sharp & Dohme LLC
- Industry
- Eligibility
- 18 Years to 65 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2011
- U.S. locations
- 2
- States / cities
- Fort Myers, Florida • Miramar, Florida
- Conditions
- Vitiligo
- Interventions
- ARQ-252 cream 0.3%, ARQ-252 Vehicle cream, NB-UVB phototherapy active treatment, NB-UVB phototherapy sham treatment
- Drug · Device
- Lead sponsor
- Arcutis Biotherapeutics, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 114 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021
- U.S. locations
- 5
- States / cities
- San Diego, California • Coral Gables, Florida • Rolling Meadows, Illinois + 2 more
- Conditions
- Atopic Dermatitis
- Interventions
- Pimecrolimus, Placebo
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 2 Years to 11 Years
- Enrollment
- 200 participants
- Timeline
- 2005 – 2006
- U.S. locations
- 1
- States / cities
- Novartis Pharmaceuticals, New Jersey
- Conditions
- Dermatitis, Atopic
- Interventions
- Pimecrolimus plus topical corticosteroid (TCS), Pimecrolimus vehicle (Placebo) plus topical corticosteroid (TCS)
- Drug
- Lead sponsor
- Novartis
- Industry
- Eligibility
- 2 Years to 17 Years
- Enrollment
- 400 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2007
- U.S. locations
- 13
- States / cities
- Huntington Beach, California • San Diego, California • Denver, Colorado + 10 more
- Conditions
- Plaque Psoriasis
- Interventions
- Tapinarof Cream, 1%, Vtama® (Tapinarof) Cream, 1%, Placebo Control
- Drug
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 575 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2025 – 2026
- U.S. locations
- 1
- States / cities
- Hawthorne, New York
- Conditions
- Raynaud's Phenomenon Secondary to Connective Tissue Disease
- Interventions
- Vascana (0.9% nitroglycerin cream), Vehicle Cream (placebo)
- Drug
- Lead sponsor
- Covis Pharma S.à.r.l.
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 65 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016
- U.S. locations
- 1
- States / cities
- Multiple Locations, Pennsylvania
- Conditions
- Rosacea
- Interventions
- Oxymetazoline Hydrochloride, Rhofade Cream, 1%, Placebo
- Drug
- Lead sponsor
- Actavis Inc.
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 1,105 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2019 – 2020
- U.S. locations
- 1
- States / cities
- Lynchburg, Virginia
- Conditions
- Chronic Diabetic Foot Ulcers
- Interventions
- ON101 Cream, Vehicle Cream
- Drug · Other
- Lead sponsor
- Oneness Biotech Co., Ltd.
- Industry
- Eligibility
- 18 Years to 80 Years
- Enrollment
- 12 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2022
- U.S. locations
- 14
- States / cities
- Mesa, Arizona • Carlsbad, California • Castro Valley, California + 11 more
- Conditions
- Diabetic Foot Ulcers
- Interventions
- ofloxacin, MSI-78
- Drug
- Lead sponsor
- Abeona Therapeutics, Inc
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 584 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1994 – 1996
- U.S. locations
- 1
- States / cities
- Seattle, Washington
- Conditions
- Breast Cancer
- Interventions
- HylaCare, Placebo
- Drug
- Lead sponsor
- University of Texas Southwestern Medical Center
- Other
- Eligibility
- 18 Years to 99 Years · Female only
- Enrollment
- 28 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2012 – 2015
- U.S. locations
- 1
- States / cities
- Dallas, Texas
- Conditions
- Psoriasis
- Interventions
- Placebo Cream, Ruxolitinib Phosphate
- Other · Drug
- Lead sponsor
- Incyte Corporation
- Industry
- Eligibility
- 18 Years to 75 Years
- Enrollment
- 199 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2009
- U.S. locations
- 28
- States / cities
- Hot Springs, Arkansas • Los Angeles, California • San Diego, California + 25 more
- Conditions
- Interdigital Tinea Pedis
- Interventions
- Econazole Nitrate, placebo
- Drug
- Lead sponsor
- AmDerma
- Industry
- Eligibility
- 12 Years to 18 Years
- Enrollment
- 42 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2011 – 2012
- U.S. locations
- 1
- States / cities
- San Diego, California
- Conditions
- Tinea Pedis
- Interventions
- Experimental: Ketoconazole 2% Cream (Douglas Pharmaceuticals America Ltd.), Active comparator: Ketoconazole 2% Cream (Teva Pharmaceuticals USA), Placebo comparator: Placebo (Douglas Pharmaceuticals America Ltd.)
- Drug
- Lead sponsor
- Douglas Pharmaceuticals America Ltd
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 682 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2020
- U.S. locations
- 2
- States / cities
- Brandon, Florida • Tampa, Florida
- Conditions
- Tinea Pedis
- Interventions
- Experimental Drug SESC 01, Placebo, Terbinafine Hydrochloride
- Drug
- Lead sponsor
- South End Skin Care
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 90 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017
- U.S. locations
- 1
- States / cities
- Milford, Massachusetts
- Conditions
- Vulvar and Vaginal Atrophy
- Interventions
- Estrace® Cream, Estradiol Vaginal Cream, Vehicle Cream
- Drug
- Lead sponsor
- Prasco LLC
- Industry
- Eligibility
- 30 Years to 75 Years · Female only
- Enrollment
- 540 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2018
- U.S. locations
- 27
- States / cities
- Sacramento, California • San Diego, California • Denver, Colorado + 23 more
- Conditions
- Tinea Pedis
- Interventions
- Butenafine cream 1% manufactured by Taro, Lotrimin Ultra (butenafine) 1%, Butenafine Vehicle manufactured by Taro
- Drug
- Lead sponsor
- Sun Pharmaceutical Industries, Inc.
- Industry
- Eligibility
- 12 Years and older
- Enrollment
- 548 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008
- U.S. locations
- 16
- States / cities
- Burbank, California • San Diego, California • Miami, Florida + 13 more